ArticleMolecular and cellular biochemistry2020

Bcl-2/Bcl-xL inhibitor navitoclax increases the antitumor effect of Chk1 inhibitor prexasertib by inducing apoptosis in pancreatic cancer cells via inhibition of Bcl-xL but not Bcl-2.

Yoshihito Morimoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.